Pulmonx Corporation logo LUNG - Pulmonx Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 4
HOLD 4
SELL 1
STRONG
SELL
0
| PRICE TARGET: $10.00 DETAILS
HIGH: $20.00
LOW: $2.50
MEDIAN: $9.75
CONSENSUS: $10.00
UPSIDE: 545.16%
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Revenue
Revenue 90.5 83.8 68.7 53.7 48.4 32.7 32.6 20.0
Cost of Revenue 23.4 21.8 17.9 13.8 12.8 11.5 10.2 7.7
Gross Profit 67.1 62.0 50.8 39.9 35.6 21.2 22.4 12.3
Operating Expenses
R&D Expenses 19.5 17.6 18.1 15.4 13.1 7.5 6.0 7.0
SG&A Expenses 101.3 102.1 94.6 83.1 69.9 46.1 34.2 20.3
Other Expenses 0 0 0 0 0 0 0 0
Operating Expenses 120.8 119.7 112.7 98.5 82.9 53.5 40.3 27.3
Operating Income
Operating Income (53.7) (57.7) (61.9) (58.6) (47.3) (32.3) (17.8) (15.1)
Interest Expense 3.2 3.5 3.2 1.1 0.8 3.2 2.3 2.5
Interest Income 2.7 5.1 5.6 1.5 0.4 0.2 0.4 0.0
Profitability
EBITDA (52.6) (50.8) (55.1) (56.0) (46.6) (28.4) (16.8) (15.7)
EBIT (53.7) (52.4) (57.0) (57.5) (47.5) (28.8) (18.0) (15.9)
Income Before Tax (53.4) (55.9) (60.3) (58.6) (48.3) (32.0) (20.3) (18.5)
Income Tax Expense 0.6 0.5 0.6 0.4 0.3 0.2 0.4 0.0
Net Income (54.0) (56.4) (60.8) (58.9) (48.7) (32.2) (20.7) (18.5)
Per Share Data
EPS (Basic) -1.33 -1.44 -1.60 -1.59 -1.35 -0.90 -0.58 -0.89
EPS (Diluted) -1.33 -1.44 -1.60 -1.59 -1.35 -0.90 -0.58 -0.89
Shares Outstanding 40.7 39.1 38.0 37.1 36.1 35.7 35.4 20.7
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Current Assets
Cash & Cash Equivalents 70.0 70.9 83.5 101.7 148.5 231.8 14.8 4.1
Short-Term Investments 0 30.6 33.6 39.4 31.6 0 13.6 0
Net Receivables 12.1 13.8 13.0 9.3 6.9 4.6 6.0 3.4
Inventory 15.8 16.9 16.7 14.6 16.3 10.7 5.6 3.3
Other Current Assets 3.8 1.4 0.7 0.5 0.6 0.4 0.7 0.1
Total Current Assets 101.7 136.2 150.4 169.0 208.0 250.0 41.1 11.3
Non-Current Assets
Property, Plant & Equipment 20.2 21.5 7.4 10.5 12.9 10.4 7.5 0.4
Goodwill 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3
Intangible Assets 0 0 0.0 0.2 0.3 0.4 0.5 0.6
Long-Term Investments 0 0 14.4 5.9 10.9 0 0 0
Other Non-Current Assets 5.0 2.8 3.2 5.8 0.7 0.5 2.1 0.3
Total Non-Current Assets 27.6 26.6 27.4 24.7 27.2 13.7 12.5 3.7
Total Assets 129.3 162.8 177.8 193.7 235.2 263.7 53.5 15.0
Current Liabilities
Account Payables 3.9 3.8 1.5 1.8 1.6 1.5 2.7 1.3
Short-Term Debt 1.3 3.2 2.2 0.1 0.1 2.2 0 0
Deferred Revenue 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1
Other Current Liabilities 14.6 6.9 7.9 5.0 4.7 3.1 6.5 2.5
Total Current Liabilities 20.1 24.4 23.2 18.5 17.6 12.5 14.2 8.1
Non-Current Liabilities
Long-Term Debt 37.0 34.0 35.1 17.2 17.3 17.4 220.3 33.6
Deferred Tax Liabilities 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0
Other Non-Current Liabilities 0 0 0 0 0.2 0 0 140.6
Total Non-Current Liabilities 55.1 52.6 36.3 21.2 24.4 25.0 226.8 174.3
Total Liabilities 75.2 77.0 59.5 39.7 41.9 37.6 240.9 182.3
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (521.6) (467.6) (411.2) (350.3) (291.4) (242.7) (210.5) (189.8)
Accumulated Other Comprehensive Income 2.4 2.1 2.6 1.6 1.7 1.7 1.4 1.3
Total Stockholders' Equity 54.1 85.8 118.3 154.0 193.2 226.1 (187.4) (167.3)
Total Liabilities & Equity 129.3 162.8 177.8 193.7 235.2 263.7 53.5 15.0
Debt Metrics
Total Debt 56.4 56.5 41.4 24.4 26.5 27.2 227.2 33.6
Net Debt (13.6) (14.4) (42.1) (77.3) (122.0) (204.6) 212.4 29.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Operating Activities
Net Income (54.0) (56.4) (60.8) (58.9) (48.7) (32.2) (20.7) (18.5)
Depreciation & Amortization 1.2 1.5 1.5 4.0 3.2 0.5 0.4 0.3
Stock-Based Compensation 0 23.0 22.1 0 0 3.2 0.4 0.4
Change in Working Capital (1.9) (1.7) (2.6) (7.1) (7.8) (4.8) (2.4) (1.5)
Other Non-Cash Items 22.3 2.1 2.1 16.8 11.9 2.7 0.9 0.0
Operating Cash Flow (32.4) (31.5) (37.6) (45.1) (41.4) (30.6) (20.8) (18.4)
Investing Activities
Capital Expenditure (0.5) (1.4) (0.8) (1.3) (3.7) (0.9) (0.7) (0.3)
Acquisitions 0 0 0 0 0 0 13.5 0.0
Purchases of Investments (5.7) (27.9) (46.2) (47.2) (52.6) 0 (21.4) 0
Sales/Maturities of Investments 36.6 46.8 45 44.3 10 13.6 7.9 0.5
Other Investing Activities 0 0 0 0 0 0 (13.5) 0.0
Investing Cash Flow 30.5 17.5 (2.0) (4.2) (46.3) 12.7 (14.2) 0.2
Financing Activities
Net Debt Issuance (0.1) (0.1) 19.9 (0.1) 0 33.0 6 12
Stock Repurchased 0 0 0 (0.0) (0.0) 0 (0.0) 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0 1.5 1.5 0 0 0.4 (0.1) 0.1
Financing Cash Flow 0.9 1.4 21.4 2.5 4.5 234.8 45.6 12.1
Cash Position
Net Change in Cash (1.2) (12.6) (18.2) (46.7) (83.1) 217.0 10.6 (5.9)
Cash at Beginning 71.2 83.8 102.0 148.7 231.8 14.8 4.1 10.1
Cash at End 70.0 71.2 83.8 102.0 148.7 231.8 14.8 4.1
Free Cash Flow (32.9) (33.0) (38.4) (46.5) (45.1) (31.5) (21.5) (18.7)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018
Income Statement
Revenue 90.5 83.8 68.7 53.7 48.4 32.7 32.6 20.0
Gross Profit 67.1 62.0 50.8 39.9 35.6 21.2 22.4 12.3
Operating Income (53.7) (57.7) (61.9) (58.6) (47.3) (32.3) (17.8) (15.1)
Net Income (54.0) (56.4) (60.8) (58.9) (48.7) (32.2) (20.7) (18.5)
EPS (Diluted) -1.33 -1.44 -1.60 -1.59 -1.35 -0.90 -0.58 -0.89
Balance Sheet
Cash & Equivalents 70.0 70.9 83.5 101.7 148.5 231.8 14.8 4.1
Total Assets 129.3 162.8 177.8 193.7 235.2 263.7 53.5 15.0
Total Debt 56.4 56.5 41.4 24.4 26.5 27.2 227.2 33.6
Stockholders' Equity 54.1 85.8 118.3 154.0 193.2 226.1 (187.4) (167.3)
Cash Flow
Operating Cash Flow (32.4) (31.5) (37.6) (45.1) (41.4) (30.6) (20.8) (18.4)
Capital Expenditure (0.5) (1.4) (0.8) (1.3) (3.7) (0.9) (0.7) (0.3)
Free Cash Flow (32.9) (33.0) (38.4) (46.5) (45.1) (31.5) (21.5) (18.7)